Roman Yelensky

Roman Yelensky

Company: Gristone Bio

Job title: Executive Vice President & Chief Technology Officer


Evaluating Neoantigen Immunotherapies in the Clinic 12:00 pm

Utilizing advances in genomic analysis and interpretation for therapeutic development Selection of therapeutically useful neoantigens for immunization Integrating immune monitoring and cell free DNA (cfDNA) to evaluate immunotherapies clinicallyRead more

day: Track B - Day 2 AM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.